{"schema_version":"1.0","hypothesis_id":35462,"triple":{"drug":"Dimethyl fumarate","drug_canonical":"dimethyl fumarate","mediator":"Nrf2","mediator_canonical":"NRF2","outcome":"efficacy of synthetic anti-rheumatic drugs","outcome_canonical":"efficacy of synthetic anti-rheumatic drugs"},"domain":{"domain":"cross_domain","source":"multiple_sclerosis","target":"rheumatoid_arthritis"},"provenance_completeness":"partial_backfill","completeness_notes":"Backfilled retroactively from DB state on 2026-05-13. The pipeline_run this row references was created by the backfill script, not by the actual generation orchestrator. Source papers, claims, scoring, and embedding config are recovered; generation-time metadata (exact git commit at gen time, host, exact command) is not recoverable.","source_papers":[{"doi":"10.1007/s00204-024-03683-9","pmid":"38368281","year":2024,"roles":["drug_mediator"],"title":"Identification of key neuronal mechanisms triggered by dimethyl fumarate in SH-SY5Y human neuroblastoma cells through a metabolomic approach","journal":"Arch Toxicol","work_id":208599,"publication_date":"2024-02-18"},{"doi":"10.1172/jci.insight.165974","pmid":"37751291","year":2023,"roles":["drug_mediator"],"title":"Dimethyl fumarate modulates the dystrophic disease program following short-term treatment","journal":"JCI Insight","work_id":201936,"publication_date":"2023-09-26"},{"doi":"10.1016/j.freeradbiomed.2022.08.012","pmid":"35964840","year":2022,"roles":["mediator_outcome"],"title":"Pros and cons of NRF2 activation as adjunctive therapy in rheumatoid arthritis","journal":"Free Radic Biol Med","work_id":290626,"publication_date":"2022-08-11"},{"doi":"10.1186/s12883-022-02604-6","pmid":"35260109","year":2022,"roles":["drug_mediator"],"title":"Familial multiple sclerosis in patients with Von Hippel-Lindau disease","journal":"BMC Neurol","work_id":213870,"publication_date":"2022-03-08"},{"doi":"10.3390/antiox11051015","pmid":"35624879","year":2022,"roles":["drug_mediator"],"title":"Thyroid Disorders in Patients Treated with Dimethyl Fumarate for Multiple Sclerosis: A Retrospective Observational Study","journal":"Antioxidants (Basel)","work_id":213467,"publication_date":"2022-05-21"},{"doi":"10.3390/molecules28010107","pmid":"36615301","year":2022,"roles":["drug_mediator"],"title":"Anti-Inflammatory Effect of Dimethyl Fumarate Associates with the Inhibition of Thioredoxin Reductase 1 in RAW 264.7 Cells","journal":"Molecules","work_id":205513,"publication_date":"2022-12-23"},{"doi":"10.1177/17448069221124920","pmid":"36065971","year":2022,"roles":["drug_mediator"],"title":"Dimethyl fumarate attenuates pain behaviors in osteoarthritis rats <i>via</i> induction of Nrf2-mediated mitochondrial biogenesis","journal":"Mol Pain","work_id":197632,"publication_date":"2022-06-01"},{"doi":"10.1177/23971983211016196","pmid":"35005243","year":2021,"roles":["drug_mediator"],"title":"A pilot study of dimethyl fumarate in pulmonary arterial hypertension associated with systemic sclerosis","journal":"J Scleroderma Relat Disord","work_id":210091,"publication_date":"2021-05-28"},{"doi":"10.3390/antiox10020193","pmid":"33572792","year":2021,"roles":["drug_mediator"],"title":"Prevention of Autoimmune Diabetes in NOD Mice by Dimethyl Fumarate","journal":"Antioxidants (Basel)","work_id":205192,"publication_date":"2021-01-29"},{"doi":"10.2174/1567202618666211109105024","pmid":"34751118","year":2021,"roles":["drug_mediator"],"title":"Protective Effect of GSK-3β/Nrf2 Mediated by Dimethyl Fumarate in Middle Cerebral Artery Embolization Reperfusion Rat Model","journal":"Curr Neurovasc Res","work_id":200858,"publication_date":"2021-08-01"},{"doi":"10.3390/antiox10010028","pmid":"33396641","year":2020,"roles":["drug_mediator"],"title":"Peripheral Blood NRF2 Expression as a Biomarker in Human Health and Disease","journal":"Antioxidants (Basel)","work_id":204053,"publication_date":"2020-12-30"},{"doi":"10.3892/mmr.2020.11342","pmid":"32945364","year":2020,"roles":["drug_mediator"],"title":"Protective effect of dimethyl fumarate on oxidative damage and signaling in cardiomyocytes","journal":"Mol Med Rep","work_id":204049,"publication_date":"2020-07-15"},{"doi":"10.1038/s41419-020-02890-3","pmid":"32811823","year":2020,"roles":["drug_mediator"],"title":"Computational repositioning of dimethyl fumarate for treating alcoholic liver disease","journal":"Cell Death Dis","work_id":198474,"publication_date":"2020-08-18"},{"doi":"10.1293/tox.2018-0049","pmid":"31092974","year":2019,"roles":["drug_mediator"],"title":"Dimethyl fumarate ameliorates cisplatin-induced renal tubulointerstitial lesions","journal":"J Toxicol Pathol","work_id":204280,"publication_date":"2019-01-01"},{"doi":"10.1177/0271678x19858888","pmid":"31220996","year":2019,"roles":["drug_mediator"],"title":"Treatment with dimethyl fumarate reduces the formation and rupture of intracranial aneurysms: Role of Nrf2 activation","journal":"J Cereb Blood Flow Metab","work_id":203864,"publication_date":"2019-06-20"},{"doi":"10.12659/msm.918951","pmid":"31645538","year":2019,"roles":["drug_mediator"],"title":"The Effects of Dimethyl Fumarate on Atherosclerosis in the Apolipoprotein E-Deficient Mouse Model with Streptozotocin-Induced Hyperglycemia Mediated By the Nuclear Factor Erythroid 2-Related Factor 2/Antioxidant Response Element (Nrf2/ARE) Signaling Pathway","journal":"Med Sci Monit","work_id":199147,"publication_date":"2019-10-24"},{"doi":"10.1038/s41467-019-11139-3","pmid":"31300673","year":2019,"roles":["drug_mediator"],"title":"Therapeutic efficacy of dimethyl fumarate in relapsing-remitting multiple sclerosis associates with ROS pathway in monocytes","journal":"Nat Commun","work_id":196149,"publication_date":"2019-07-12"},{"doi":"10.1177/1352458518791132","pmid":"30051766","year":2018,"roles":["drug_mediator"],"title":"Dimethyl fumarate–associated transient bone marrow oedema syndrome","journal":"Mult Scler","work_id":212317,"publication_date":"2018-07-27"},{"doi":"10.18632/oncotarget.24144","pmid":"29507676","year":2018,"roles":["drug_mediator"],"title":"Dimethyl fumarate is highly cytotoxic in KRAS mutated cancer cells but spares non-tumorigenic cells","journal":"Oncotarget","work_id":198887,"publication_date":"2018-01-10"},{"doi":"10.1530/jme-18-0102","pmid":"30038053","year":2018,"roles":["drug_mediator"],"title":"Dimethyl fumarate accelerates wound healing under diabetic conditions","journal":"J Mol Endocrinol","work_id":198849,"publication_date":"2018-07-23"}],"source_paper_count":20,"extracted_claims":[{"side":"drug_mediator","object":"Nrf2","context":"in relapsing-remitting multiple sclerosis","subject":"dimethyl fumarate","work_id":196149,"claim_id":140676,"polarity":"positive","predicate":"activates","confidence":0.8,"extraction_run_id":25},{"side":"drug_mediator","object":"Nrf2","context":"in a rat model of osteoarthritis","subject":"dimethyl fumarate","work_id":197632,"claim_id":143502,"polarity":"positive","predicate":"activates","confidence":0.95,"extraction_run_id":25},{"side":"drug_mediator","object":"NRF2","context":"in liver cells","subject":"dimethyl fumarate","work_id":198474,"claim_id":145010,"polarity":"positive","predicate":"upregulates","confidence":0.95,"extraction_run_id":25},{"side":"drug_mediator","object":"NRF2","context":"in diabetic and non-diabetic mice","subject":"Dimethyl fumarate","work_id":198849,"claim_id":145635,"polarity":"positive","predicate":"activates","confidence":0.9,"extraction_run_id":25},{"side":"drug_mediator","object":"NRF2","context":"in non-tumorigenic cells","subject":"Dimethyl fumarate","work_id":198887,"claim_id":145713,"polarity":"positive","predicate":"activates","confidence":0.9,"extraction_run_id":25},{"side":"drug_mediator","object":"Nrf2","context":"in apo-E-deficient mouse model with STZ-induced hyperglycemia","subject":"dimethyl fumarate","work_id":199147,"claim_id":146123,"polarity":"positive","predicate":"upregulates","confidence":0.9,"extraction_run_id":25},{"side":"drug_mediator","object":"Nrf2","context":"in MCAO/R rat model","subject":"dimethyl fumarate","work_id":200858,"claim_id":148795,"polarity":"positive","predicate":"upregulates","confidence":0.95,"extraction_run_id":25},{"side":"drug_mediator","object":"NRF2","context":"general","subject":"Dimethyl fumarate","work_id":201936,"claim_id":150499,"polarity":"positive","predicate":"activates","confidence":0.9,"extraction_run_id":25},{"side":"drug_mediator","object":"Nrf2","context":"in VSMCs and in mice","subject":"dimethyl fumarate","work_id":203864,"claim_id":152967,"polarity":"positive","predicate":"upregulates","confidence":0.9,"extraction_run_id":25},{"side":"drug_mediator","object":"Nrf2","context":"in H9c2 cells subjected to myocardial ischemia/reperfusion","subject":"dimethyl fumarate","work_id":204049,"claim_id":153293,"polarity":"positive","predicate":"activates","confidence":0.8,"extraction_run_id":25},{"side":"drug_mediator","object":"NRF2","context":"as an NRF2-activating drug","subject":"dimethyl fumarate","work_id":204053,"claim_id":153291,"polarity":"positive","predicate":"activates","confidence":0.9,"extraction_run_id":25},{"side":"drug_mediator","object":"Nrf2","context":"in rats","subject":"Dimethyl fumarate","work_id":204280,"claim_id":153586,"polarity":"positive","predicate":"activates","confidence":0.9,"extraction_run_id":25},{"side":"drug_mediator","object":"Nrf2","context":"in NOD mice","subject":"dimethyl fumarate","work_id":205192,"claim_id":154816,"polarity":"positive","predicate":"activates","confidence":0.7,"extraction_run_id":25},{"side":"drug_mediator","object":"NRF2","context":"in RAW 264.7 cells","subject":"Dimethyl fumarate","work_id":205513,"claim_id":155264,"polarity":"positive","predicate":"activates","confidence":0.8,"extraction_run_id":25},{"side":"drug_mediator","object":"Nrf2","context":"in SH-SY5Y cells","subject":"dimethyl fumarate","work_id":208599,"claim_id":159037,"polarity":"positive","predicate":"activates","confidence":0.8,"extraction_run_id":25},{"side":"drug_mediator","object":"Nrf2","context":"in patients with SSc-PAH","subject":"dimethyl fumarate","work_id":210091,"claim_id":160871,"polarity":"positive","predicate":"activates","confidence":0.95,"extraction_run_id":25},{"side":"drug_mediator","object":"Nrf2","context":"in multiple sclerosis treatment","subject":"Dimethyl fumarate","work_id":212317,"claim_id":162857,"polarity":"positive","predicate":"downregulates","confidence":0.8,"extraction_run_id":25},{"side":"drug_mediator","object":"Nrf2","context":"in multiple sclerosis patients","subject":"Dimethyl fumarate","work_id":213467,"claim_id":163681,"polarity":"positive","predicate":"activates","confidence":0.9,"extraction_run_id":25},{"side":"drug_mediator","object":"Nrf2","context":"FDA-approved therapeutic for multiple sclerosis","subject":"dimethyl fumarate","work_id":213870,"claim_id":163943,"polarity":"positive","predicate":"activates","confidence":0.8,"extraction_run_id":25},{"side":"mediator_outcome","object":"efficacy of synthetic anti-rheumatic drugs","context":"in rheumatoid arthritis","subject":"NRF2","work_id":290626,"claim_id":222758,"polarity":"positive","predicate":"decreases","confidence":0.7,"extraction_run_id":29}],"extracted_claim_count":20,"extraction":{"model":"deepseek-v4-flash","model_source":"configured","prompt_version":"v1_2026_05_07","run_ids":[25,29]},"bridge":{"a_to_b_predicate":"activates","b_to_c_predicate":"decreases","a_to_b_evidence_count":19,"b_to_c_evidence_count":1,"edge_support_log_ab":2.995732273553991,"edge_support_log_bc":0.6931471805599453,"novelty_factor":1.0,"direct_a_to_c_count":0},"embedding":{"model":"bge-m3","dim":1024,"max_length":8192,"similarity_scores":{}},"scoring":{"method":"swanson_abc_log_evidence_with_novelty_penalty","formula":"score = min((log(ab+1) + log(bc+1)) * novelty / 10, 1.0); novelty = 1.0 if direct==0 else 0.7 / (direct+1)","score_raw":0.36888794541139364,"score":0.36888794541139364,"quality_tier":"high","quality_reason":null},"pipeline_run":{"id":4,"run_uuid":"eb8b7730-d92e-4cd5-95dd-95f6c5d62cc2","command":"scripts/backfill_provenance_v2.py:v2_2026_05_12","status":"completed","git_commit":"9996ffaa56e9b7cd5f677bd8203624c2c18aa000","host":"MacBook-Pro-Daniel96.local","started_at":"2026-05-12T21:35:53.363326+00:00","ended_at":"2026-05-12T21:43:41.903387+00:00","notes":"Retroactive provenance backfill on 2026-05-13 for snapshot v2_2026_05_12. Synthetic pipeline_runs row — original generation run records are lost (pre-date provenance schema). All recoverable fields populated from current DB state (claims, works, repurposing_hypotheses); pipeline_run record is synthetic, hence completeness='partial_backfill'.\nBackfilled 1,618 provenance rows. Source papers: avg=3.73, zero=0. Claims matched: avg=4.09, zero=0.\nRefreshed 1,618 provenance rows. Source papers: avg=3.73, zero=0. Claims matched: avg=4.09, zero=0.\nRefreshed 1,618 provenance rows. Source papers: avg=3.73, zero=0. Claims matched: avg=4.09, zero=0.","domains":["als","alzheimer","depression","epilepsy","glioblastoma","inflammatory_bowel_disease","multiple_sclerosis","pancreatic_cancer","rheumatoid_arthritis","type_2_diabetes"]},"generated_at":"2026-05-12T21:43:40.945575+00:00"}